drugset / Trial / NCT05556148

Otrivine: Quality of Life (QoL) Impact in a Real-World Setting

NCT05556148

Phase 4 Completed 136 enrolled HALEON
NaSingle-groupOpen-labelTreatment

Summary

This study is designed to generate real world data from participants with nasal congestion acquired from common cold following treatment with a marketed nasal spray. The main purpose of this study is to evaluate the effectiveness of a nasal spray on quality of life (QoL) factors.

Timeline

Start
2022-11-07
Primary completion
2022-12-20
Completion
2022-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Xylometazoline Small molecule 0.1 % Intranasal

Indications